Another negative Ivermectin randomized trial of 500 high-risk patients, with more negative randomized trials to come soonhttps://t.co/Y8vUFeeQjv @JAMAInternalMed— Eric Topol (@EricTopol) February 18, 2022
Another negative Ivermectin randomized trial of 500 high-risk patients, with more negative randomized trials to come soonhttps://t.co/Y8vUFeeQjv @JAMAInternalMed